CRISPR THERAPEUTICS AG financial statements, including revenue, expenses, profit, and loss
The total revenue of CRSP/N for the last quarter is 8.35 M MXN, and it's 99.76% lower compared to the previous quarter. The net income of Q1 24 is -1.93 B MXN.